The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 701–800 of 1,039
Dandona, P., & Aljada, A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02556-0 · Cited by 137
Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome
Prieur, X., Rőszer, T., & Ricote, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.017 · Cited by 129
Self-citationMaffei, R., Bulgarelli, J., Fiorcari, S., Bertoncelli, L., Martinelli, S., Guarnotta, C., Castelli, I., Deaglio, S., Debbia, G., De Biasi, S., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.073080 · Cited by 116
Nosjean, O., & Boutin, J. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00281-9 · Cited by 132
Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ Agonists
Padilla, J., Leung, E., & Phipps, R. P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5181 · Cited by 133
Hayden, J. M., & Reaven, P. D. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00010 · Cited by 122
Citral, a component of lemongrass oil, activates PPARα and γ and suppresses COX-2 expression
Katsukawa, M., Nakata, R., Takizawa, Y., Hori, K., Takahashi, S., & Inoue, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.07.004 · Cited by 120
Peroxisome Proliferator-Activated Receptor-α Enhances Lipid Metabolism in a Skin Equivalent Model
Rivier, M., Safonova, I., Michel, S., Castiel, I., & Ailhaud, G. P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00939.x · Cited by 127
Aoki, Y., Maeno, T., Aoyagi, K., Ueno, M., Aoki, F., Aoki, N., Nakagawa, J., Sando, Y., Shimizu, Y., Suga, T., et al. (2008) · Respiration · doi:10.1159/000168676 · Cited by 125
PPAR influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
Nicol, C. J. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh160 · Cited by 120
Pal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 124
Ciavarella, C., Motta, I., Valente, S., & Pasquinelli, G. (2020) · Molecules · doi:10.3390/molecules25092076 · Cited by 138
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease
Belvisi, M. G., & Mitchell, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00373.x · Cited by 127
Moyes, K. M., Drackley, J. K., Morin, D. E., Bionaz, M., Rodriguez‐Zas, S. L., Everts, R. E., Lewin, H. A., & Loor, J. J. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-542 · Cited by 127
Westergaard, M., Henningsen, J., Rasmussen, S., Kristiansen, K., Johansen, C., Svendsen, M. L., Jensen, U. B., Schrøder, H. D., Staels, B., Iversen, L., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12536.x · Cited by 128
Diab, A., Hussain, R. Z., Lovett‐Racke, A. E., Chavis, J. A., Drew, P. D., & Racke, M. K. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.010 · Cited by 125
The effect of PPARγ ligands on the adipose tissue in insulin resistance
Hammarstedt, A., Andersson, C. X., Sopasakis, V. R., & Smith, U. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.04.008 · Cited by 135
Maternal selenium status during early gestation and risk for preterm birth
Rayman, M., Wijnen, H. A. A., Vader, H. L., Kooistra, L., & Pop, V. J. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101095 · Cited by 130
Alfranca, A., Iñiguez, M. A., Fresno, M., & Redondo, J. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.020 · Cited by 118
Baumann, K. H., Hessel, F., Larass, I., Müller, T., Angerer, P., Kiefl, R., & von Schacky, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.59 · Cited by 116
Keshamouni, V. G., Arenberg, D. A., Reddy, R. C., Newstead, M. J., Anthwal, S., & Standiford, T. J. (2005) · Neoplasia · doi:10.1593/neo.04601 · Cited by 127
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Sponseller, C. A., Hampton, K., & Bacon, B. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00027-8 · Cited by 128
Zhang-Gandhi, C. X., & Drew, P. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.007 · Cited by 117
“Previously, we and others have demonstrated that PPARs also are important modulators of inflammation (Kielian and Drew, 2003; Ricote et al., 1998).”
BackgroundLichen Planopilaris Treated With a Peroxisome Proliferator–Activated Receptor γ Agonist
Mirmirani, P., & Karnik, P. (2009) · Archives of Dermatology · doi:10.1001/archdermatol.2009.283 · Cited by 123
Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice
Liang, H., Suk, F., Wang, C.-K., Hung, L.-F., Liu, D.-Z., Chen, N.-Q., Chen, Y.-C., Chang, C., & Liang, Y. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.08.003 · Cited by 117
Yokoyama, M., & Origasa, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00367-3 · Cited by 127
Hortelano, S., Castrillo, A., Alvarez, A. M., & Boscá, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6525 · Cited by 118
Neuroinflammation: a potential therapeutic target
Craft, J. M., Watterson, D. M., & Van Eldik, L. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.887 · Cited by 116
Role of 15-DeoxyΔ 12,14 Prostaglandin J 2 and Nrf2 Pathways in Protection against Acute Lung Injury
Mochizuki, M., Ishii, Y., Itoh, K., Iizuka, T., Morishima, Y., Kimura, T., Kiwamoto, T., Matsuno, Y., Hegab, A. E., Nomura, A., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-755oc · Cited by 118
Rahman, S. M., Janssen, R. C., Choudhury, M., Baquero, K. C., Aikens, R. M., de la Houssaye, B. A., & Friedman, J. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410613 · Cited by 115
Feinstein, D. L. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503763816481 · Cited by 115
Shah, S., Iqbal, M., Karam, J., Salifu, M., & McFarlane, S. I. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1629 · Cited by 115
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 118
Yu, J., Qiu, Y., Yang, J., Bian, S., Chen, G., Deng, M., Kang, H., & Huang, L. J. (2016) · Scientific Reports · doi:10.1038/srep30053 · Cited by 122
Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligands
Barros, C. D., Amato, A. A., de Oliveira, T. B., Iannini, K. B. R., da Silva, A. L., da Silva, T. G., Leite, E. S., Hernandes, M. Z., de Lima, M. D. C. A., Galdino, S. L., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.045 · Cited by 115
PPARγ and its ligands: therapeutic implications in cardiovascular disease
Villacorta, L., Schopfer, F. J., Zhang, J., Freeman, B. Α., & Chen, Y. (2009) · Clinical Science · doi:10.1042/cs20080195 · Cited by 118
DNA Binding-Independent Induction of I B Gene Transcription by PPAR
Delerive, P. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.1029 · Cited by 114
Satoh, T., Toyoda, M., Hoshino, H., Monden, T., Yamada, M., Shimizu, H., Miyamoto, K., & Mori, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205279 · Cited by 120
Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C., & Rossi, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6232 · Cited by 131
Pötgens, S. A., Brossel, H., Sboarina, M., Catry, E., Cani, P. D., Neyrinck, A. M., Delzenne, N. M., & Bindels, L. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-30569-5 · Cited by 114
MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis
Schober, A., Nazari-Jahantigh, M., & Weber, C. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.38 · Cited by 121
Parsing the Role of PPARs in Macrophage Processes
Toobian, D., Ghosh, P., & Katkar, G. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783780 · Cited by 120
Shiner, M., Fuhrman, B., & Aviram, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.01.007 · Cited by 124
Wu, J.-S., Cheung, W.-M., Tsai, Y.-S., Chen, Y.-T., Fong, W.-H., Tsai, H.-D., Chen, Y.-C., Liou, J.-Y., Shyue, S.-K., Chen, J.-J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.812537 · Cited by 114
McTigue, D. M., Tripathi, R. B., Wei, P. Y., & Lash, A. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.009 · Cited by 118
Mbalaviele, G., Abu-Amer, Y., Meng, A., Jaiswal, R., Beck, S., Pittenger, M. F., Thiede, M. A., & Marshak, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14388 · Cited by 114
Okamoto, H., Iwamoto, T., Kotake, S., Momohara, S., Yamanaka, H., & Kamatani, N. (2005) · PubMed · Cited by 128
Greaves, D. R., Gough, P. J., & Gordon, S. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00006 · Cited by 122
Abdellatif, K. R. A., Fadaly, W. A. A., Kamel, G. M., Elshaier, Y. A. M. M., & El‐Magd, M. A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.09.034 · Cited by 121
Ponferrada, Á., Caso, J. R., Alou, L., Rodríguez, A. C., Sevillano, D., Moro, M. Á., Lizasoaín, I., Menchén, P. L., Gómez-Lus, M. L., Lorenzo, P. L., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.032 · Cited by 126
PPARγ as a therapeutic target in central nervous system diseases
Sundararajan, S. S., Jiang, Q., Heneka, M. T., & Landreth, G. E. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.020 · Cited by 118
Cheng, S., Afif, H., Martel-Pelletier, J., Pelletier, J.-P., Li, X., Farrajota, K., Lavigne, M., & Fahmi, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402828200 · Cited by 112
Cipollone, F., Cicolini, G., & Bucci, M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.002 · Cited by 127
PGD Synthase and PGD 2 in Immune Resposne
Joo, M., & Sadikot, R. T. (2012) · Mediators of Inflammation · doi:10.1155/2012/503128 · Cited by 126
Пили, Р., Kruszewski, M., Hager, B. W., Lantz, J., & Carducci, M. A. (2001) · PubMed · Cited by 122
15-Deoxy-Δ12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
Monneret, G., Li, H., Vasilescu, J., Rokach, J., & Powell, W. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3563 · Cited by 112
Keelan, J. A., Sato, T. A., Marvin, K. W., Lander, J., Gilmour, R. S., & Mitchell, M. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1257 · Cited by 119
Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response
Malur, A., Mccoy, A. J., Arce, S., Barna, B. P., Kavuru, M. S., Malur, A. G., & Thomassen, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803504 · Cited by 108
Jennewein, C., Kuhn, A.-M., Schmidt, M. V., Meilladec-Jullig, V., von Knethen, A., Gonzalez, F. J., & Brüne, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5646 · Cited by 110
Culver, D. A., Barna, B. P., Raychaudhuri, B., Bonfield, T. L., Abraham, S., Malur, A., Farver, C. F., Kavuru, M. S., & Thomassen, M. J. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0304rc · Cited by 107
Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies
Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/367838 · Cited by 109
Comparative toxicity of fatty acids on a macrophage cell line (J774)
de Lima, T. M., Cury‐Boaventura, M. F., Giannocco, G., Nunes, M. T., & Curi, R. (2006) · Clinical Science · doi:10.1042/cs20060064 · Cited by 118
Inflammation and immune responses in atherosclerosis
Greaves, D. R., & Channon, K. M. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02331-1 · Cited by 111
Decker, T., & Kovarik, P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050393 · Cited by 120
Shiojiri, T., Wada, K., Nakajima, A., Katayama, K., Shibuya, A., Kudo, C., Kadowaki, T., Mayumi, T., Yura, Y., & Kamisaki, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01946-5 · Cited by 120
Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury
Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110
Thiazolidinediones as anti‐inflammatory and anti‐atherogenic agents
Ceriello, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.790 · Cited by 109
Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
Rogue, A., Lambert, C., Jossé, R., Antherieu, S., Spire, C., Claude, N., & Guillouzo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018816 · Cited by 105
Shimano, M., Tsuji, Y., Inden, Y., Kitamura, K., Uchikawa, T., Harata, S., Nattel, S., & Murohara, T. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.12.010 · Cited by 113
Prostaglandins and Rheumatoid Arthritis
Fattahi, M. J., & Mirshafiey, A. (2012) · Arthritis · doi:10.1155/2012/239310 · Cited by 115
Diabetes, Inflammation, Proinflammatory Cytokines, and Diabetic Nephropathy
Navarro, J. F., & Mora, C. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.179 · Cited by 109
Bosetti, F., Weerasinghe, G. R., Rosenberger, T. A., & Rapoport, S. I. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01701.x · Cited by 108
Peroxisome proliferator-activated receptors and cardiovascular remodeling
Schiffrin, E. L. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00677.2004 · Cited by 113
Van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G., & De Baetselier, P. (2006) · Blood · doi:10.1182/blood-2005-09-3777 · Cited by 110
Dietary and Microbial Metabolites in the Regulation of Host Immunity
Shibata, N., Kunisawa, J., & Kiyono, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02171 · Cited by 112
Pparg signaling controls bladder cancer subtype and immune exclusion
Tate, T., Xiang, T., Wobker, S. E., Zhou, M., Chen, X., Kim, H.-W., Batourina, E., Lin, C., Kim, W. Y., Lü, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26421-6 · Cited by 116
Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00425.x · Cited by 119
Wakino, S., Hayashi, K., Kanda, T., Tatematsu, S., Homma, K., Yoshioka, K., Takamatsu, I., & Saruta, T. (2004) · Circulation Research · doi:10.1161/01.res.0000142313.68389.92 · Cited by 109
Notch signaling in vascular morphogenesis
Alva, J. A., & Iruela-Arispe, M. L. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000130309.44976.ad · Cited by 109
Cipollone, F., Fazia, M. L., Iezzi, A., Ciabattoni, G., Pini, B., Cuccurullo, C., Ucchino, S., Spigonardo, F., Luca, M. D., Prontera, C., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000133192.39901.be · Cited by 109
RetractedThe pleiotropic function of PPARγ in the placenta
Schaiff, W. T., Barak, Y., & Sadovsky, Y. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.02.009 · Cited by 117
Jaradat, M., Wongsud, B., Phornchirasilp, S., Rangwala, S. M., Shams, G. E.-D. A. M., Sutton, M., Romstedt, K. J., Noonan, D. J., & Feller, D. R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00822-x · Cited by 122
Nie, M., Pang, L., Inoue, H., & Knox, A. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9233-9244.2003 · Cited by 119
Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s Disease
Blasko, I., & Grubeck-Loebenstein, B. (2003) · Drugs & Aging · doi:10.2165/00002512-200320020-00002 · Cited by 108
The role of adipose tissue in mediating the beneficial effects of dietary fish oil
Puglisi, M. J., Hasty, A. H., & Saraswathi, V. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.003 · Cited by 103
Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies
Robinson, G., Pineda‐Torra, I., Ciurtin, C., & Jury, E. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148552 · Cited by 115
Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis
Shimizu, K. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2249-7 · Cited by 118
García‐Bueno, B., Madrigal, J. L. M., Lizasoaín, I., Moro, M. Á., Lorenzo, P. L., & Leza, J. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.007 · Cited by 117
Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids
Yang, C., Chen, W., Wu, P., Tseng, H., & Lee, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017764 · Cited by 109
López‐Cabrera, M. (2014) · Advances in Medicine · doi:10.1155/2014/473134 · Cited by 108
Okada, M., Yan, S. F., & Pinsky, D. J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0503com · Cited by 115
Majdalawieh, A. F., & Ro, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/823821 · Cited by 124
PPARγ Controls Dectin-1 Expression Required for Host Antifungal Defense against Candida albicans
Galès, A., Conduché, A., Bernad, J., Lefevre, L., Olagnier, D., Béraud, M., Martin-Blondel, G., Linas, M.-D., Auwerx, J., Coste, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000714 · Cited by 96
Serghides, L., & Kain, K. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6742 · Cited by 121
Wang, P., Anderson, P. O., Chen, S., Paulsson, K. M., Sjögren, H. O., & Li, S. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00015-7 · Cited by 124
Kim, S., Hong, J.-H., & Lee, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.033 · Cited by 112
Pereira, M. P., Hurtado, O., Cárdenas, A., Boscá, L., Castillo, J., Dávalos, A., Vivancos, J., Serena, J., Lorenzo, P., Lizasoain, I., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600182 · Cited by 107
Li, J., Guo, C., & Wu, J. (2019) · PPAR Research · doi:10.1155/2019/7242030 · Cited by 109
Fan, W., Yanase, T., Morinaga, H., Mu, Y.-M., Nomura, M., Okabe, T., Goto, K., Harada, N., & Nawata, H. (2004) · Endocrinology · doi:10.1210/en.2004-1046 · Cited by 116
Veillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 127
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.